Company research / SPRY
ARS Pharmaceuticals, Inc. (SPRY)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, ARS Pharmaceuticals, Inc. reported revenue of $84.28M. Revenue fell 5.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $116.93M.
Key ratios (year ended 2025-12-31)
-212.9%
Operating margin
-203.3%
Net margin
-149.9%
Return on year-end equity
-5.5%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.